by Daniel F. Kripke, M.D. | Nov 9, 2017 | Blog, Daniel F Kripke MD, Medical Professional Awareness, Research
NOTE: Dr. Kripke is responding to a study by Elisabetta Patorno, Robert J Glynn, Raisa Levin, Moa P Lee, and Krista F Huybrechts entitled Benzodiazepines and risk of all cause mortality in adults: cohort study. To date, Dr. Kripke’s questions have not been...
by Daniel F. Kripke, M.D. | Sep 8, 2017 | Blog, Daniel F Kripke MD, Government Action
Chairs and Members of the Committee on Mental Health and Substance Abuse Massachusetts Legislature Dear Friends: The Benzodiazepine Information Coalition asked me to send you a letter in support of Bill H.3594 that I understand you are considering. I am a research...
by Daniel F. Kripke, M.D. | Jul 30, 2017 | Blog, Daniel F Kripke MD, Medical Professional Awareness, Research
Abstract: Abstract Hypnotics (sleeping pills) are prescribed widely, but the economic costs of the harm they have caused have been largely unrecognized. Randomized clinical trials have observed that hypnotics increase the incidence of infections. Likewise, hypnotics...
![Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 2; referees: 2 approved]](https://www.benzoinfo.com/wp-content/uploads/2017/04/KripkeBlog-1080x675.jpg)
by Daniel F. Kripke, M.D. | Apr 15, 2017 | Blog, Daniel F Kripke MD, Medical Professional Awareness, Research
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sleeping pills). The...
Recent Comments